HOUSTON, Feb. 18, 2021 /PRNewswire/ -- Soliton, Inc.,
(Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device
company with a novel and proprietary platform technology, today
announced that the company's Rapid Acoustic Pulse (RAP) device
received the Best New Technology Award from the Aesthetic Industry
Association (AIA).
The Soliton RAP device uses proprietary design acoustic
shockwaves to mechanically disrupt targeted cellular structures in
a completely non-invasive therapy. The clinically proven Rapid
Acoustic Pulse (RAP) device was recently cleared by the FDA for
temporary improvement in the appearance of cellulite. It had
been previously cleared as an accessory to the 1064 nm Q-Switched
laser for black ink tattoo removal in Fitzpatrick Skin Type I-III
patients.
"We are honored to be the first recipient of this award from the
Aesthetic Industry Association. We are thrilled to have our
innovative technology recognized in this manner by industry peers
and leaders. We are excited to further demonstrate the benefits of
the RAP device to the AIA audience that includes physicians in the
aesthetic industry and patients interested in tattoo removal and
cellulite appearance reduction," commented Brad Hauser, Soliton CEO and President.
Join our more than 200K
subscribers here to follow the
Company: https://soly-investors.com
The Aesthetic Industry Association (AIA) is the first and only
member-driven organization dedicated to the long-term health,
sustainability, and development of the $14
Billion medical aesthetic industry. For more information
about AIA, please visit:
https://miinews.com/aesthetic-industry-association
About Soliton, Inc.
Soliton, Inc. is a medical device company with a novel and
proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer
Center. The Company's first FDA cleared commercial product will use
rapid pulses of acoustic shockwaves as an accessory to lasers for
the removal of unwanted tattoos and the treatment of cellulite. The
Company is based in Houston,
Texas, and is actively engaged in bringing the Rapid
Acoustic Pulse ("RAP") device to the market. The Company believes
this "Soliton" method has the potential to lower tattoo removal
costs for patients, while increasing profitability to
practitioners, compared to current laser removal methods. Soliton
is investigating potential additional capabilities of the RAP
technology. The device is currently cleared in the United States only for use in tattoo
removal and cellulite.
For more information about the Company, please visit:
http://www.soliton.com
Forward-Looking Statements
Some of the statements in this release are forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934 and the
Private Securities Litigation Reform Act of 1995, which involve
risks and uncertainties. These statements relate to future
events, future expectations, plans and prospects. Although Soliton
believes that the expectations reflected in such forward-looking
statements are reasonable as of the date made, expectations may
prove to have been materially different from the results expressed
or implied by such forward-looking statements. Soliton has
attempted to identify forward-looking statements by terminology
including ''believes,'' ''estimates,'' ''anticipates,''
''expects,'' ''plans,'' ''projects,'' ''intends,'' ''potential,''
''may,'' ''could,'' ''might,'' ''will,'' ''should,''
''approximately'' or other words that convey uncertainty of future
events or outcomes to identify these forward-looking statements.
These statements are only predictions and involve known and unknown
risks, uncertainties, and other factors, including those discussed
under in our SEC filings, including under the heading "Item 1A.
Risk Factors" in the Form 10-K for year ended December 31, 2019 we filed with the SEC on
March 2, 2020 and updated from time
to time in our Form 10-Q filings and in our other public filings
with the SEC. Any forward-looking statements contained in this
release speak only as of its date. Soliton undertakes no obligation
to update any forward-looking statements contained in this release
to reflect events or circumstances occurring after its date or to
reflect the occurrence of unanticipated events.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/soliton-named-best-new-technology-award-at-the-aesthetic-industry-association-board-meeting-301230446.html
SOURCE Soliton, Inc.